UCHL1 and cholangiocarcinoma: Therefore, understanding the molecular alterations associated with UCHL1 hypomethylation-induced upregulation, targeted therapies can be developed to modulate UCHL1 expression, offering a potential avenue for therapeutic intervention in Ov-CCA.